2010-13292. Memorandum of Understanding by and Between the United States Food and Drug Administration and the International Anesthesia Research Society for the Safety of Key Inhaled and Intravenous Drugs in Pediatrics Public-Private Partnership  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the International Anesthesia Research Society (IARS). The purpose of this MOU is to establish a framework for collaboration between FDA and IARS and to support their shared interest of promoting the safe use of anesthetics and sedatives in children.

    DATES:

    The agreement became effective March 21, 2010.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Wendy R. Sanhai, Senior Scientific Advisor, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 4128, Silver Spring, MD 20993, 301-796-8518.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

    Start Signature

    Dated: May 26, 2010.

    Leslie Kux,

    Acting Assistant Commissioner for Policy.

    End Signature Start Printed Page 31451

    Start Printed Page 31452

    Start Printed Page 31453

    Start Printed Page 31454

    Start Printed Page 31455

    Start Printed Page 31456

    Start Printed Page 31457

    End Supplemental Information

    BILLING CODE 4160-01-S

    [FR Doc. 2010-13292 Filed 6-2-10; 8:45 am]

    BILLING CODE 4160-01-C

Document Information

Comments Received:
0 Comments
Effective Date:
3/21/2010
Published:
06/03/2010
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2010-13292
Dates:
The agreement became effective March 21, 2010.
Pages:
31450-31457 (8 pages)
Docket Numbers:
Docket No. FDA-2010-N-0004, FDA 225-09-0014
PDF File:
2010-13292.pdf